You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK)擬在杭州醫藥港小鎮投建實驗室設施
格隆匯 09-22 19:57

格隆匯 9 月 22日丨維亞生物(01873.HK)發佈公告,2020年9月22日,公司直接全資附屬公司維亞(香港)與杭州錢塘新區管理委員會就該項目簽署投資協議。根據投資協議,維亞(香港)已同意透過項目公司在杭州錢塘新區內項目土地上建設實驗室設施,並已承諾投資人民幣7億元作為該項目的固定資產投資,將於未來數年內逐步完成。預期項目土地上的實驗室設施將於2024年開始營運。

根據投資協議,維亞(香港)將成立項目公司,而項目公司將建設及成立一間藥物化學研發實驗室及一間配套的分析實驗室。項目公司將引入及支持創新研發項目孵化。杭州錢塘新區管理委員會已同意於項目公司完成公司註冊、外商投資備案及税務登記後,將不遲於2020年11月底前開始項目土地的土地拍賣程序(土地使用權為期50年)。項目土地為一幅位於杭州醫藥港小鎮內的工業用地,總土地面積約為40畝(相當於約2.67萬平方米)。

公告稱,集團為中國的綜合性藥物發現平台,預期該項目將為集團在杭州開展孵化創新研發項目提供額外的實驗室設施及孵化器空間。該項目為集團提供於獲政府支持的製藥港口建立據點並擴展其現有業務的機會。集團預計,該項目將使集團進一步加強其合約研發能力、物色其他潛在的孵化投資組合公司以及滿足其未來的業務發展需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account